CGS-CIMB Research retains Add for Duopharma, lower TP of RM1.90
KUALA LUMPUR: CGS-CIMB Equities Research is maintaining its Add call for Duopharma Biotech with a lower target price of RM1.90
Read moreKUALA LUMPUR: CGS-CIMB Equities Research is maintaining its Add call for Duopharma Biotech with a lower target price of RM1.90
Read moreETALING JAYA: Widad Group Bhd has been appointed the sub-contractor for the design and construction of the new solid-waste transfer
Read morePETALING JAYA: Handal Resources Bhd’s wholly owned subsidiary, Handal Offshore Services Sdn Bhd, has been awarded a contract for the
Read moreKUALA LUMPUR: The first batch of contract house officers (HOs) completed their two-year training at the end of last year
Read more